Endo International | ENDP - Vermögenswerte



Vermögenswerte Veränderung Datum
AbbVie USD 135.12B 1.35B 2026-06
Amarin USD 624.36M 21.4M 2026-06
ANI Pharmaceuticals USD 1.49B 72.14M 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Coherus Biosciences USD 191.18M 74.84M 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Heron Therapeutics USD 252.26M 6.05M 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Ligand Pharmaceuticals USD 2.19B 653.77M 2026-06
Merck USD 129.8B 1.12B 2026-06
Novartis USD 122.03B 3.5B 2026-06
Pacira USD 1.24B 35.44M 2026-06
Perrigo USD 7.61B 373.8M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Phibro Animal Health USD 1.5B 56.12M 2026-06
Supernus Pharmaceuticals USD 1.43B 72.62M 2026-06
Takeda JPY 15.66T 210.16B 2026-06
Teva Pharmaceutical Industries USD 39.86B 183M 2026-06
Xeris Pharmaceuticals USD 411.9M 19.89M 2026-06
Zoetis USD 15.08B 77M 2026-06